IMRN
Price
$1.84
Change
+$0.01 (+0.55%)
Updated
Sep 2, 04:48 PM (EDT)
Capitalization
10.48M
ZLDPF
Price
$68.81
Change
+$2.81 (+4.26%)
Updated
Aug 28 closing price
Capitalization
4.85B
Interact to see
Advertisement

IMRN vs ZLDPF

Header iconIMRN vs ZLDPF Comparison
Open Charts IMRN vs ZLDPFBanner chart's image
Immuron
Price$1.84
Change+$0.01 (+0.55%)
Volume$8.51K
Capitalization10.48M
Zealand Pharma A/S
Price$68.81
Change+$2.81 (+4.26%)
Volume$153
Capitalization4.85B
IMRN vs ZLDPF Comparison Chart in %
Loading...
IMRN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZLDPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IMRN vs. ZLDPF commentary
Sep 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IMRN is a StrongBuy and ZLDPF is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 03, 2025
Stock price -- (IMRN: $1.83 vs. ZLDPF: $68.81)
Brand notoriety: IMRN and ZLDPF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IMRN: 19% vs. ZLDPF: 28%
Market capitalization -- IMRN: $10.48M vs. ZLDPF: $4.85B
IMRN [@Biotechnology] is valued at $10.48M. ZLDPF’s [@Biotechnology] market capitalization is $4.85B. The market cap for tickers in the [@Biotechnology] industry ranges from $100.25B to $0. The average market capitalization across the [@Biotechnology] industry is $1.85B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IMRN’s FA Score shows that 1 FA rating(s) are green whileZLDPF’s FA Score has 2 green FA rating(s).

  • IMRN’s FA Score: 1 green, 4 red.
  • ZLDPF’s FA Score: 2 green, 3 red.
According to our system of comparison, ZLDPF is a better buy in the long-term than IMRN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IMRN’s TA Score shows that 5 TA indicator(s) are bullish while ZLDPF’s TA Score has 5 bullish TA indicator(s).

  • IMRN’s TA Score: 5 bullish, 4 bearish.
  • ZLDPF’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, ZLDPF is a better buy in the short-term than IMRN.

Price Growth

IMRN (@Biotechnology) experienced а +2.81% price change this week, while ZLDPF (@Biotechnology) price change was +12.80% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.83%. For the same industry, the average monthly price growth was +22.37%, and the average quarterly price growth was +32.94%.

Industries' Descriptions

@Biotechnology (+6.83% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ZLDPF($4.85B) has a higher market cap than IMRN($10.5M). IMRN YTD gains are higher at: 7.647 vs. ZLDPF (-32.776). ZLDPF has higher annual earnings (EBITDA): 7.27B vs. IMRN (-7.35M). ZLDPF has more cash in the bank: 16.6B vs. IMRN (7.74M). ZLDPF has higher revenues than IMRN: ZLDPF (9.11B) vs IMRN (6.54M).
IMRNZLDPFIMRN / ZLDPF
Capitalization10.5M4.85B0%
EBITDA-7.35M7.27B-0%
Gain YTD7.647-32.776-23%
P/E RatioN/A4.75-
Revenue6.54M9.11B0%
Total Cash7.74M16.6B0%
Total DebtN/A397M-
FUNDAMENTALS RATINGS
IMRN vs ZLDPF: Fundamental Ratings
IMRN
ZLDPF
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
21
Undervalued
34
Fair valued
PROFIT vs RISK RATING
1..100
10072
SMR RATING
1..100
9719
PRICE GROWTH RATING
1..100
5859
P/E GROWTH RATING
1..100
10025
SEASONALITY SCORE
1..100
8590

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

IMRN's Valuation (21) in the Biotechnology industry is in the same range as ZLDPF (34) in the null industry. This means that IMRN’s stock grew similarly to ZLDPF’s over the last 12 months.

ZLDPF's Profit vs Risk Rating (72) in the null industry is in the same range as IMRN (100) in the Biotechnology industry. This means that ZLDPF’s stock grew similarly to IMRN’s over the last 12 months.

ZLDPF's SMR Rating (19) in the null industry is significantly better than the same rating for IMRN (97) in the Biotechnology industry. This means that ZLDPF’s stock grew significantly faster than IMRN’s over the last 12 months.

IMRN's Price Growth Rating (58) in the Biotechnology industry is in the same range as ZLDPF (59) in the null industry. This means that IMRN’s stock grew similarly to ZLDPF’s over the last 12 months.

ZLDPF's P/E Growth Rating (25) in the null industry is significantly better than the same rating for IMRN (100) in the Biotechnology industry. This means that ZLDPF’s stock grew significantly faster than IMRN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
IMRNZLDPF
RSI
ODDS (%)
N/A
Bearish Trend 5 days ago
55%
Stochastic
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 5 days ago
69%
Momentum
ODDS (%)
Bullish Trend 5 days ago
75%
Bullish Trend 5 days ago
57%
MACD
ODDS (%)
Bullish Trend 5 days ago
75%
Bullish Trend 5 days ago
62%
TrendWeek
ODDS (%)
Bullish Trend 5 days ago
67%
Bullish Trend 5 days ago
57%
TrendMonth
ODDS (%)
Bullish Trend 5 days ago
69%
Bullish Trend 5 days ago
58%
Advances
ODDS (%)
Bullish Trend 5 days ago
74%
Bullish Trend 16 days ago
72%
Declines
ODDS (%)
Bearish Trend 14 days ago
89%
N/A
BollingerBands
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 5 days ago
63%
Aroon
ODDS (%)
Bearish Trend 5 days ago
82%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
IMRN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZLDPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SDFI35.940.06
+0.17%
AB Short Duration Income ETF
CLOU22.920.02
+0.09%
Global X Cloud Computing ETF
DBEZ51.75-0.38
-0.72%
Xtrackers MSCI Eurozone Hedged Eq ETF
ICLN14.39-0.13
-0.90%
iShares Global Clean Energy ETF
GGRW34.11-0.35
-1.01%
Gabelli Growth Innovators ETF

IMRN and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMRN has been closely correlated with RIGL. These tickers have moved in lockstep 82% of the time. This A.I.-generated data suggests there is a high statistical probability that if IMRN jumps, then RIGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMRN
1D Price
Change %
IMRN100%
+0.55%
RIGL - IMRN
82%
Closely correlated
-1.17%
CLNN - IMRN
80%
Closely correlated
-1.66%
AZTR - IMRN
72%
Closely correlated
+9.18%
PHIO - IMRN
72%
Closely correlated
-0.51%
ZLDPF - IMRN
52%
Loosely correlated
N/A
More

ZLDPF and

Correlation & Price change

A.I.dvisor indicates that over the last year, ZLDPF has been loosely correlated with IMRN. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if ZLDPF jumps, then IMRN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ZLDPF
1D Price
Change %
ZLDPF100%
N/A
IMRN - ZLDPF
52%
Loosely correlated
+0.55%
MNMD - ZLDPF
32%
Poorly correlated
-9.20%
VICP - ZLDPF
28%
Poorly correlated
N/A
GLSI - ZLDPF
26%
Poorly correlated
+0.17%
LTRN - ZLDPF
23%
Poorly correlated
+0.49%
More